Analgesic Efficacy of Local Anesthetic Transversus Abdominis Plane (TAP) Blocks in Abdominal Surgery

NCT ID: NCT00682136

Last Updated: 2010-06-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1

Total Enrollment

206 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-04-30

Study Completion Date

2009-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to establish the efficacy of local anaesthetic TAP (transversus abdominis plane) blocks in providing pain relief in the first 24hrs following open or laparoscopic elective abdominal colorectal operations.

TAP blocks involve the injection of local aesthetic (ropivicaine) into the transversus abdominis plane in the abdominal wall. This injection takes place after induction of anaesthesia, but before the commencement of surgery. TAP blocks have been proposed as a potential safer alternative to epidural anaesthesia. The blocks have been extensively used in the Hunter New England system over the last 18 months. As yet there is no clear evidence for there efficacy, hence the need for this trial.

This trial would establish the efficacy of this practice. If the technique proves effective it could be widely used and provide a simpler method of managing post operative pain.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Open Laparotomy Arm: All patients enrolled in the study who are undergoing elective open laparotomy surgery.

Group Type ACTIVE_COMPARATOR

US-Guided Ropivacaine TAP Block

Intervention Type PROCEDURE

Bilateral injection of local anaesthetic into the Transversus Abdominis plane, guided by ultrasound.

2

Laparoscopic Arm: All patients enrolled in the study who are undergoing elective laparoscopic abdominal surgery.

Group Type ACTIVE_COMPARATOR

US-Guided Ropivacaine TAP Block

Intervention Type PROCEDURE

Bilateral injection of local anaesthetic into the Transversus Abdominis plane, guided by ultrasound.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

US-Guided Ropivacaine TAP Block

Bilateral injection of local anaesthetic into the Transversus Abdominis plane, guided by ultrasound.

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

TAP Block

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients aged 18 and over undergoing elective open or laparoscopic colorectal surgery performed by the participating surgeons within the study period will be considered for the trial.

Exclusion Criteria

* History of adverse reaction to Ropivicaine or similar drug.
* Inability or refusal to give consent
* Coagulopathic
* Severe renal impairment
* Aged \<18 years
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hunter Colorectal Research

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hunter Colerectal Research

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Brian Draganic, B.Med.,B.Med.Sci.(Hons),FRACS

Role: PRINCIPAL_INVESTIGATOR

Hunter Colorectal Research

Stephen Smith, B.Med.,F.R.A.C.S.

Role: PRINCIPAL_INVESTIGATOR

Hunter Colorectal Research

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

John Hunter Hospital

New Lambton, New South Wales, Australia

Site Status

Newcastle Private Hospital

New Lambton, New South Wales, Australia

Site Status

Private Medical Suites

New Lambton, New South Wales, Australia

Site Status

Mater Misericordiae Hospital

Waratah, New South Wales, Australia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Australia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

08/02/20/3.02

Identifier Type: -

Identifier Source: secondary_id

TAPTRIAL

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

TAP Block for Postoperative Pain Control
NCT02652156 TERMINATED PHASE3
Cool Pre-operative TAP Blocks
NCT04761887 WITHDRAWN PHASE1